USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/34435
Title: NUTRITION OF THE CRITICALLY ILL PATIENT WITH ACUTE PANCREATITIS
Authors: Bulhac, Bogdan-Grigorie
Olaru-Stăvilă, Cătălina
Keywords: acute pancreatitis;enteral nutrition;parenteral nutrition;oral nutrition
Issue Date: 2026
Publisher: Centrul Editorial-Poligrafic Medicina
Citation: Bulhac, Bogdan-Grigorie; Olaru-Stăvilă, Cătălina. NUTRITION OF THE CRITICALLY ILL PATIENT WITH ACUTE PANCREATITIS. In: MedEspera 2026, p. 620. ISBN 978-9975-82-486-6.
Abstract: Introduction. Acute pancreatitis (AP) is one of the leading causes of gastrointestinal morbidity and mortality worldwide, with approximately 20% of cases progressing to necrotising forms. In this clinical context, the severe hypercatabolic and hypermetabolic state induced by the systemic inflammatory response necessitates the early initiation of artificial nutritional support. Consequently, optimising nutritional management is a cornerstone in reducing mortality among patients with severe disease. Aim of study. The objective of this study is to synthesise recent literature regarding nutritional strategies in acute pancreatitis and to establish updated clinical recommendations. Methods and materials. The study evaluates 22 publications developed between 2017 and 2025, identified in PubMed, Google Scholar, ResearchGate, and Scopus databases, which provide nutritional recommendations for patients with acute pancreatitis. Results. Given the hypercatabolic status of AP, the feeding strategy is adjusted based on disease severity and requires a systematic assessment of nutritional risk to enable the earliest possible initiation of nutritional support. Thus, in patients with mild AP, if clinically tolerated, oral nutrition with a hypolipidemic diet is indicated from the first 24 hours. Otherwise, in patients with sepsis or who present intolerance to oral nutrition, enteral nutrition (EN) via nasogastric tube is the first line of support and should be initiated in the first 24-72 hours from the onset of the disease. The nasojejunal tube is reserved for patients with gastric stasis or those with intra-abdominal pressure (IAP) >15mmHg and requires its removal in abdominal compartment syndrome, IAP >20 mmHg. EN is associated with a reduction in infectious complications, multiorgan failure, surgical re-interventions, mortality and length of hospital stay. Probiotics are not recommended, and pancreatic enzymes are administered only in diagnosed exocrine pancreatic insufficiency. Parenteral nutrition (PN) remains reserved for patients who do not tolerate EN or when it is contraindicated. Supplementation of PN with L-glutamine, 0.2g/kg/day, contributes to improving the prognosis. Conclusions. Early initiation of nutritional therapy in AP is a cost-effective strategy, reduces the duration of hospitalisation and improves the prognosis of patients. Hypolipidemic oral nutrition is preferred in mild forms, and EN is the gold standard in severe forms of AP. PN remains a second-line option, indicated when the first two methods are contraindicated or cannot adequately meet the patient’s nutritional needs.
metadata.dc.relation.ispartof: MedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026
URI: https://medespera.md/documents/abstract-book-4.pdf
https://repository.usmf.md/handle/20.500.12710/34435
ISBN: 978-9975-82-486-6
Appears in Collections:MedEspera 2026

Files in This Item:
File Description SizeFormat 
M-620.pdf466.29 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback